Is the role of estrogens and estrogen receptors in epilepsy still underestimated?

Medical Hypotheses

Volumn 73, Issue 5, 2009, Pages 703-705

  Fucic, Aleksandra ^a   Miškov, Snjezana ^b   Želježić, Davor ^a   Bogdanovic, Nenad ^c   Katić, Jelena ^a   Gjergja, Romana ^b   Karelson, Ello ^d   Gamulin, Marija ^e  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF TARTU   (Estonia)

^e KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AROMATASE; CARBAMAZEPINE; ESTROGEN; ESTROGEN RECEPTOR; ETHOSUXIMIDE; GABAPENTIN; GALANIN; LAMOTRIGINE; NEUROPEPTIDE Y; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; QUININE; SOMATOSTATIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ALCOHOL CONSUMPTION; ARTICLE; DRUG MECHANISM; DRUG RESPONSE; ENDOCRINE DISEASE; EPILEPSY; ESTROGEN ACTIVITY; GENE MUTATION; HUMAN; KETOGENIC DIET; MALARIA; PHOTOSTIMULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE; SLEEP; SUBFERTILITY;

EPILEPSY; ESTROGENS; HUMANS; RECEPTORS, ESTROGEN;

EID: 70349750157     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.051     Document Type: Article

References (48)

1. Fisher R.S., van Emde Boas W., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 46 4 (2005) 470-472
2. Isojarvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure (2008) 111-119
3. Jacobsen N.W., Halling-Sorensen B., and Birkved F.K. Inhibition of human aromatase complex (CYP 19) by antiepileptic drugs. Toxicology in Vitro 22 (2008) 146-153
4. Winum J.Y., Scozzafava A., Montero J.L., and Supuran C.T. Therapeutic application of sulfamates. Expert Opinion on Therapeutic Patents 14 9 (2004) 1273-1308
5. Yeow W.-S., Ziauddin M.F., Maxhiemer J.B., et al. Potentation of the anticancer effect of valproic, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor staurosporine on its clinically relevant analogue UCN-01. Brit J Cancer 94 (2006) 1436-1445
6. Yi X., Wei W., Wang S.Y., Du Zy., Xu Y.J., and Yu X.D. Histone deacetylase inhibitor induces ER alpha degradation in breast cancer MCF-7 cells by CHIP mediated ubiquitin pathway and inhibits survival signaling. Biochem Pharmacol 75 9 (2008) 1697-1705
7. Hart S.A., Snyder M.A., Smejkalova T., and Woolley C.S. Estrogen mobilizes a subset of estrogen receptor-alfa-immunoreactive vesicles in inhibitory presynaptic buttons in hippocampal CA1. J Neurosci 27 8 (2007) 2102-2111
8. Rhodes M.E., Talluri J., Harney J., and Frye C.A. Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats. Epilepsy Behav 7 2 (2005) 231-239
9. Cavus I., Pan J.W., Hetherington H.P., et al. Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients. Epilepsia 49 8 (2008) 1358-1366
10. Xu X., Sun R., and Jin R. The effect of ketogenic diet on hippocampal GluR5 and GluR6 m RNA expressions and Q/R site editing in the kainate-induced epilepsy model. Epilepsy Behav 13 3 (2008) 445-448
11. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., and McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrionol 29 (2008) 219-237
12. Cheng C.M., Hicks K., Wang J., Eagles D.A., and Bondy C.A. Caloric restriction augments brain glutamic acid decarboxylase-65 and 67 expression. J Neurosci Res 77 2 (2004) 270-276
13. Ikeda T., Matsuki N., and Yamada M.K. Estrogen produced in cultured hippocampal neurons is a functional regulator of a GABAergic machinery. J Neurosci Res 84 89 (2006) 1771-1777
14. Klein P., van Passe-Clark L.M., and Pezzutllo J.C. Onset of epilepsy at the time of menarche. Neurology 60 3 (2003) 495-497
15. Brodiem M.J. Epilepsy: randomized trials and genetic tribulations. Neurol. Lancet 7 (2008) 7-8
16. Ngoungou E.B., Koko J., Druet-Cabanac M., et al. Cerebral malaria and squealer epilepsy: first matched case-control study in Gabon. Epilepsia 47 12 (2006) 2147-2153
17. Reviere J.H., and Back D.J. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivates in vitro. Chem Biol Interact 59 3 (1986) 301-308
18. Taylor W.R., and White N.J. Antimalarian drug toxicity: a review. Drug Saf 27 1 (2004) 25-61
19. McClean J., and Nunez J.L. 17 alpha estradiol is neuroprotective in male and female rats in a model early brain injury. Exp Neurol 210 1 (2008) 41-50
20. Abizaid A., Mezei G., Thanarajasingam G., and Horvath T.L. Estrogen enhances light activation of dorsal raphe serotonergic neurons. Eur J Neurosci 21 6 (2005) 1536-1546
21. Coutelle C., Hohn B., Benesova M., et al. Risk factor in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens. Int J Oncol 25 4 (2004) 1127-1132
22. Crawford P., and Lee P. Gender difference in management of epilepsy-what women are hearing?. Seizure 83 3 (1999) 135-139
23. Montouris G., and Morris G.L. Reproductive and sexual dysfunction in men with epilepsy. Epilepsy Behav 7 (2005) 7-14
24. Sheth R.D., Binkley N., and Hermann P.B. Gender differences in bone mineral density in epilepsy. Epilepsia 49 1 (2008) 125-131
25. Gnant M.F.X., Mlineritsch B., Luschin-Ebengreuth G., et al. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian breast and colorectal cancer study group. J Clin Oncol 25 7 (2007) 820-828
26. Quian Y., and Zeng F. Re-establishment of spermatogenesis by diethylstilbestrol after 2,5-hexanedione-induced irreversible testicular atrophy in rats. J Huazhong Univ Sci Technol Med Sci 28 2 (2008) 179-181
27. Castaldo P., del Giuidice E.M., Coppola G., Pascotto Annunziato L., and Tagliatela M. Benign familial neonatal convulsions caused by alters gating of KCNQ2/KCNQ3 potassium channels. J Neurosci 22 (2002) 1-6
28. + channel signaling in the arcute nucleus. Endocrinology 148 10 (2007) 4937-4951
29. Heron S.E., Cox K., and Grinton B.E. Deletions or duplication in KCNQ2 can cause benign familial neonatal seizures. J Med Genet 44 2 (2007) 791-796
30. Kow L.M., Devidzem N., Patakym S., Shubuyam I., and Pfaff D.W. Acute estradiol application increases inward and decrease outward whole-cell currents of neurons in rat hypothalamic ventromedial nucleus. Brain Res 1116 1 (2006) 1-11
31. Smitherman K.A., and Sontheimer H. Inhibition of glial Na and K currents by tamoxifen. J Membr Biol 181 2 (2001) 125-135
32. Beggs J., Nakada S., Fenoglio K., Wu J., and Kerrigan J.F. Hypothalamic hamartomas associated with epilepsy: ultrastructural features. J Neuropathol Exp Neurol 67 7 (2008) 657-668
33. Heron S.E., Scheffer I.E., Berkovic S.F., Dibbens L.M., and Mulley J.C. Channelopathies in idiopathic epilepsy. Neurotherapeutics 4 2 (2007) 295-304
34. Shenoy S.N., and Raja A. Hypothalamic hamartoma with precocious puberty. Pediatr Neurosurg 40 5 (2004) 249-252
35. McCarthy M.M. Estradiol and the developing brain. Physiol Rev 88 (2007) 91-134
36. Sakuma S., Tokuhara D., Hattori H., Matsuoka O., and Yamaro T. Expression of estrogen receptor alpha and beta in reactive astrocytes at the male rat hippocampus after status epilepticus. Neuropathology (2008) 10.1111/j.1440-1789.2008.00946
37. Uenoyama Y., Tsukamura H., and Kinoshita M. Oestrogen-dependent stimulation of luteinising hormone release by galanin-like peptide in female rats. J Neuroendocrinol 20 5 (2008) 626-631
38. Lerner J.T., Sankar R., and Mazarati A.M. Galanin-25 years with a multitalented neuropeptides: galanin and epilepsy. Cell Mol Sci 65 12 (2008) 1864-1871
39. Kimura N., Takamatsu N., Yaoita Y., Osamura R.Y., and Kimura N. Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promotor and regions including estrogen response element half-site for estrogen activation. J Mol Endocrinol 40 2 (2008) 75-91
40. Amlai H., Faroqui S., Balasubramaniam A., and Sheriff S. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer Res 66 7 (2006) 3706-3714
41. Mize A.L., Poisner A.M., and Alper R.H. Estrogen act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decrease in serotonin 5-HT1A receptor function. Neuroendocrinology 73 3 (2001) 166-174
42. Ish H., Tsurugizawa T., Ogiue-Ikeda M., et al. Local production of sex hormones and their modulation of hippocampal synaptic plasticity. The Neuroscientist 13 4 (2007) 323-334
43. Vasudeva N., and Pfaff D.W. Non genomic actions of estrogen and their interaction with genomic actions in the brain. Front Neurol 29 (2008) 238-257
44. Rabinowicz A.L., Starkstein S.E., Leiguarda R.C., and Coleman A.E. Transient epileptic amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering. Alzheimer Dis Assoc Disorders 14 4 (2000) 231-233
45. Moss R.L., Gu O., and Wong M. Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res 52 (1997) 33-68
46. Wooley C.S. Acute effects of estrogen on neuronal physiology. Ann Rev Pharmacol Toxicol 47 (2007) 657-680
47. Velisek L., and Veliskova J. New avenue of research: antiepileptic drug and estradiol neuroprotection in epilepsy. Recent Patents CNS Drug Discov 3 2 (2008) 128-137
48. Swerdlow A.J., Stiller C.A., and Kinnier Wilson L. Prenatal factors in the aetiology of testicular cancer: an epidemiology study of childhood testicular cancer deaths in Great Britain 1953-1973. J Epidemol Common Health 36 (1982) 96-101